6Q1.F CSAM HEALTH GROUP NK 10

Healthcare Health Care Technology Frankfurt Exchange
4.21 EUR
Close of Nov 11, 2026
3.14 4.49
Market cap
EUR 86.3M
P/E
-
P/B
46.08x
ROE
-
Dividend yield
1.03%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6Q1.F undervalued?

Graham number

The Graham number of CSAM HEALTH GROUP NK 10 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CSAM HEALTH GROUP NK 10 fundamental analysis

No fundamental analysis for CSAM HEALTH GROUP NK 10 yet.

CSAM HEALTH GROUP NK 10 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CSAM HEALTH GROUP NK 10

Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution. It also provides connected healthcare solutions, including Omda Cardio, an ECG and diagnostic storag…

Full company profile